188 related articles for article (PubMed ID: 19203722)
1. The effect of single and combined activating killer immunoglobulin-like receptor genotypes on cytomegalovirus infection and immunity after hematopoietic cell transplantation.
Zaia JA; Sun JY; Gallez-Hawkins GM; Thao L; Oki A; Lacey SF; Dagis A; Palmer J; Diamond DJ; Forman SJ; Senitzer D
Biol Blood Marrow Transplant; 2009 Mar; 15(3):315-25. PubMed ID: 19203722
[TBL] [Abstract][Full Text] [Related]
2. Expression of activating KIR2DS2 and KIR2DS4 genes after hematopoietic cell transplantation: relevance to cytomegalovirus infection.
Gallez-Hawkins GM; Franck AE; Li X; Thao L; Oki A; Gendzekhadze K; Dagis A; Palmer J; Nakamura R; Forman SJ; Senitzer D; Zaia JA
Biol Blood Marrow Transplant; 2011 Nov; 17(11):1662-72. PubMed ID: 21596150
[TBL] [Abstract][Full Text] [Related]
3. Cytomegalovirus reactivation after matched sibling donor reduced-intensity conditioning allogeneic hematopoietic stem cell transplant correlates with donor killer immunoglobulin-like receptor genotype.
Sobecks RM; Askar M; Thomas D; Rybicki L; Kalaycio M; Dean R; Avery R; Mossad S; Copelan E; Bolwell BJ
Exp Clin Transplant; 2011 Feb; 9(1):7-13. PubMed ID: 21605017
[TBL] [Abstract][Full Text] [Related]
4. Donor-recipient killer immunoglobulin like receptor (KIR) genotype matching has a protective effect on chronic graft versus host disease and relapse incidence following HLA-identical sibling hematopoietic stem cell transplantation.
Sahin U; Dalva K; Gungor F; Ustun C; Beksac M
Ann Hematol; 2018 Jun; 97(6):1027-1039. PubMed ID: 29549412
[TBL] [Abstract][Full Text] [Related]
5. Killer-cell immunoglobulin-like receptors and cytomegalovirus reactivation during late pregnancy.
Alvarado-Hernández DL; Benítez-Sánchez A; Rodríguez-Cuevas JS; Rosales-Saavedra T; Guerra-Palomares SE; Comas-García A; Noyola DE; García-Sepúlveda CA
Int J Immunogenet; 2016 Aug; 43(4):189-99. PubMed ID: 27277336
[TBL] [Abstract][Full Text] [Related]
6. Adaptive Natural Killer Cell and Killer Cell Immunoglobulin-Like Receptor-Expressing T Cell Responses are Induced by Cytomegalovirus and Are Associated with Protection against Cytomegalovirus Reactivation after Allogeneic Donor Hematopoietic Cell Transplantation.
Davis ZB; Cooley SA; Cichocki F; Felices M; Wangen R; Luo X; DeFor TE; Bryceson YT; Diamond DJ; Brunstein C; Blazar BR; Wagner JE; Weisdorf DJ; Horowitz A; Guethlein LA; Parham P; Verneris MR; Miller JS
Biol Blood Marrow Transplant; 2015 Sep; 21(9):1653-62. PubMed ID: 26055301
[TBL] [Abstract][Full Text] [Related]
7. Recipient-donor KIR ligand matching prevents CMV reactivation post-haploidentical T cell-replete transplantation.
Zhao XY; Luo XY; Yu XX; Zhao XS; Han TT; Chang YJ; Huo MR; Xu LP; Zhang XH; Liu KY; Li D; Jiang ZF; Huang XJ
Br J Haematol; 2017 Jun; 177(5):766-781. PubMed ID: 28466469
[TBL] [Abstract][Full Text] [Related]
8. Influence of donor KIR genotypes on reduced relapse risk in acute myelogenous leukemia after hematopoietic stem cell transplantation in patients with CMV reactivation.
Nakamura R; Gendzekhadze K; Palmer J; Tsai NC; Mokhtari S; Forman SJ; Zaia JA; Senitzer D; Marcucci G; Stein A
Leuk Res; 2019 Dec; 87():106230. PubMed ID: 31644966
[TBL] [Abstract][Full Text] [Related]
9. Regulation of Adaptive NK Cells and CD8 T Cells by HLA-C Correlates with Allogeneic Hematopoietic Cell Transplantation and with Cytomegalovirus Reactivation.
Horowitz A; Guethlein LA; Nemat-Gorgani N; Norman PJ; Cooley S; Miller JS; Parham P
J Immunol; 2015 Nov; 195(9):4524-36. PubMed ID: 26416275
[TBL] [Abstract][Full Text] [Related]
10. Synergistic effect of KIR ligands missing and cytomegalovirus reactivation in improving outcomes of haematopoietic stem cell transplantation from HLA-matched sibling donor for treatment of myeloid malignancies.
Cardozo DM; Marangon AV; da Silva RF; Aranha FJP; Visentainer JEL; Bonon SHA; Costa SCB; Miranda ECM; de Souza CA; Guimarães F
Hum Immunol; 2016 Oct; 77(10):861-868. PubMed ID: 27394130
[TBL] [Abstract][Full Text] [Related]
11. KIR-associated protection from CMV replication requires pre-existing immunity: a prospective study in solid organ transplant recipients.
Gonzalez A; Schmitter K; Hirsch HH; Garzoni C; van Delden C; Boggian K; Mueller NJ; Berger C; Villard J; Manuel O; Meylan P; Stern M; Hess C;
Genes Immun; 2014 Oct; 15(7):495-9. PubMed ID: 25008861
[TBL] [Abstract][Full Text] [Related]
12. [The association of killer cell immunoglobulin like receptor gene polymorphism with cytomegalovirus infection after hematopoietic stem cell transplantation].
Wu XJ; He J; Wu DP; Bao XJ; Xu C; Zhou HF; Sun AN; Han Y; Tang XW; Fu ZZ; Ma X
Zhonghua Nei Ke Za Zhi; 2013 Feb; 52(2):161-5. PubMed ID: 23967614
[TBL] [Abstract][Full Text] [Related]
13. Activating KIR genes are associated with CMV reactivation and survival after non-T-cell depleted HLA-identical sibling bone marrow transplantation for malignant disorders.
Chen C; Busson M; Rocha V; Appert ML; Lepage V; Dulphy N; Haas P; Socié G; Toubert A; Charron D; Loiseau P
Bone Marrow Transplant; 2006 Sep; 38(6):437-44. PubMed ID: 16892071
[TBL] [Abstract][Full Text] [Related]
14. Donor aKIR genes influence the risk of EBV and CMV reactivation after anti-thymocyte globulin-based haploidentical hematopoietic stem cell transplantation.
Gao F; Shi Z; Shi J; Luo Y; Yu J; Fu H; Lai X; Liu L; Yuan Z; Zheng Z; Huang H; Zhao Y
HLA; 2024 Jan; 103(1):e15320. PubMed ID: 38081622
[TBL] [Abstract][Full Text] [Related]
15. [Distribution of donor-specific aKIR after unrelated allogeneic hematopoietic stem cell transplantation].
Zhang HH; He J; Bao XJ; Hu X; Wang M; Zhang J; Wu XJ
Zhonghua Xue Ye Xue Za Zhi; 2017 May; 38(5):421-426. PubMed ID: 28565743
[No Abstract] [Full Text] [Related]
16. Genetic variants associated with cytomegalovirus infection after allogeneic hematopoietic cell transplantation.
Casto AM; Seo S; Levine DM; Storer BE; Dong X; Hansen JA; Boeckh M; Martin PJ
Blood; 2021 Oct; 138(17):1628-1636. PubMed ID: 34269803
[TBL] [Abstract][Full Text] [Related]
17. Donor KIR genotype has a major influence on the rate of cytomegalovirus reactivation following T-cell replete stem cell transplantation.
Cook M; Briggs D; Craddock C; Mahendra P; Milligan D; Fegan C; Darbyshire P; Lawson S; Boxall E; Moss P
Blood; 2006 Feb; 107(3):1230-2. PubMed ID: 16239436
[TBL] [Abstract][Full Text] [Related]
18. KIR and HLA-Cw genotypes of donor-recipient pairs influence the rate of CMV reactivation following non-T-cell deleted unrelated donor hematopoietic cell transplantation.
Wu X; He J; Wu D; Bao X; Qiu Q; Yuan X; Han Y; Sun A; Chen G; Xu Y
Am J Hematol; 2009 Nov; 84(11):776-7. PubMed ID: 19787798
[No Abstract] [Full Text] [Related]
19. [Relationship between CMV reactivation and KIR haplotype/HLA-Cw genotype in patients after unrelated-donor hematopoietic stem cell transplantation.].
Wu XJ; He J; Wu DP; Sun AN; Bao XJ; Qiu QC; Yuan XN; Li WY; Chang HR; Han Y; Ma X; Zhu ZL; Xu Y; Feng YF; Dai LJ
Zhonghua Xue Ye Xue Za Zhi; 2009 Nov; 30(11):741-4. PubMed ID: 20137308
[TBL] [Abstract][Full Text] [Related]
20. Impact of High-Frequency HLA Haplotypes on Clinical Cytomegalovirus Reactivation in Allogeneic Hematopoietic Stem Cell Transplantation.
Kawase T; Tanaka H; Kojima H; Uchida N; Ohashi K; Fukuda T; Ozawa Y; Ikegame K; Eto T; Mori T; Miyamoto T; Hidaka M; Shiratori S; Takanashi M; Atsuta Y; Ichinohe T; Kanda Y; Kanda J;
Biol Blood Marrow Transplant; 2019 Dec; 25(12):2482-2489. PubMed ID: 31400501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]